Zai Lab Limited American Depositary Shares (ZLAB) is a publicly traded Healthcare sector company. As of July 22, 2026, ZLAB trades at $20.76 with a market cap of $2.32B and a P/E ratio of -119.71. ZLAB moved +0.00% today. Year to date, ZLAB is +16.10%; over the trailing twelve months it is -40.91%. Its 52-week range spans $15.96 to $44.34. Analyst consensus is strong buy with an average price target of $32.40. Rallies surfaces ZLAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest ZLAB news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $20.76 |
| Market Cap | $2.32B |
| P/E Ratio | -119.71 |
| EPS | $-0.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $44.34 |
| 52-Week Low | $15.96 |
| Volume | 34.15K |
| Avg Volume | 0 |
| Revenue (TTM) | $453.28M |
| Net Income | $-178.12M |
| Gross Margin | 58.00% |
4 analysts cover ZLAB: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $32.40.